Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 103

1.

Emerging drugs for osteoporosis.

Feurer E, Chapurlat R.

Expert Opin Emerg Drugs. 2014 Sep;19(3):385-95. doi: 10.1517/14728214.2014.936377. Epub 2014 Jul 4. Review.

PMID:
24995794
2.

Appropriate models for novel osteoporosis drug discovery and future perspectives.

Gennari L, Rotatori S, Bianciardi S, Gonnelli S, Nuti R, Merlotti D.

Expert Opin Drug Discov. 2015;10(11):1201-16. doi: 10.1517/17460441.2015.1080685. Epub 2015 Aug 19. Review.

PMID:
26292627
3.

Status of drug development for the prevention and treatment of osteoporosis.

Schwarz P, Jørgensen NR, Abrahamsen B.

Expert Opin Drug Discov. 2014 Mar;9(3):245-53. doi: 10.1517/17460441.2014.884067. Epub 2014 Feb 4. Review.

PMID:
24490672
4.

Treatment of post-menopausal osteoporosis: beyond bisphosphonates.

Ishtiaq S, Fogelman I, Hampson G.

J Endocrinol Invest. 2015 Jan;38(1):13-29. doi: 10.1007/s40618-014-0152-z. Epub 2014 Sep 7. Review.

PMID:
25194424
5.

Emerging anabolic treatments in osteoporosis.

Mosekilde L, Tørring O, Rejnmark L.

Curr Drug Saf. 2011 Apr;6(2):62-74. Review.

PMID:
21524248
6.

Emerging anabolic agents in the treatment of osteoporosis.

Lovato C, Lewiecki EM.

Expert Opin Emerg Drugs. 2017 Sep;22(3):247-257. doi: 10.1080/14728214.2017.1362389. Epub 2017 Aug 4. Review.

PMID:
28756709
7.
8.

Established and forthcoming drugs for the treatment of osteoporosis.

Lems WF, Geusens P.

Curr Opin Rheumatol. 2014 May;26(3):245-51. doi: 10.1097/BOR.0000000000000057. Review.

PMID:
24625372
9.

The future of osteoporosis treatment - a research update.

Lippuner K.

Swiss Med Wkly. 2012 Jul 19;142:w13624. doi: 10.4414/smw.2012.13624. Review.

10.

Novel targets for the prevention of osteoporosis - lessons learned from studies of metabolic bone disorders.

Henriksen K, Thudium CS, Christiansen C, Karsdal MA.

Expert Opin Ther Targets. 2015;19(11):1575-84. doi: 10.1517/14728222.2015.1045415. Epub 2015 May 10. Review.

PMID:
25960169
11.

Anabolic therapies for osteoporosis.

Uihlein AV, Leder BZ.

Endocrinol Metab Clin North Am. 2012 Sep;41(3):507-25. doi: 10.1016/j.ecl.2012.05.002. Epub 2012 Jun 20. Review.

PMID:
22877427
12.

Management of osteoporosis in rheumatoid arthritis patients.

Hoes JN, Bultink IE, Lems WF.

Expert Opin Pharmacother. 2015 Mar;16(4):559-71. doi: 10.1517/14656566.2015.997709. Epub 2015 Jan 27. Review.

PMID:
25626121
13.

Potential new drug targets for osteoporosis.

Deal C.

Nat Clin Pract Rheumatol. 2009 Jan;5(1):20-7. doi: 10.1038/ncprheum0977. Review. Erratum in: Nat Clin Pract Rheumatol. 2009 Mar;5(3):174.

PMID:
19098925
14.

New therapeutic targets for osteoporosis: beyond denosumab.

Lim V, Clarke BL.

Maturitas. 2012 Nov;73(3):269-72. doi: 10.1016/j.maturitas.2012.08.002. Epub 2012 Aug 24. Review.

PMID:
22925430
15.

Glucocorticoid-induced osteoporosis: an update on current pharmacotherapy and future directions.

Bultink IE, Baden M, Lems WF.

Expert Opin Pharmacother. 2013 Feb;14(2):185-97. doi: 10.1517/14656566.2013.761975. Epub 2013 Jan 14. Review.

PMID:
23317448
16.

Bone anabolic versus bone anticatabolic treatment of postmenopausal osteoporosis.

Lyritis GP, Georgoulas T, Zafeiris CP.

Ann N Y Acad Sci. 2010 Sep;1205:277-83. doi: 10.1111/j.1749-6632.2010.05666.x. Review.

PMID:
20840284
17.

Effect of osteoporosis medications on fracture healing.

Hegde V, Jo JE, Andreopoulou P, Lane JM.

Osteoporos Int. 2016 Mar;27(3):861-871. doi: 10.1007/s00198-015-3331-7. Epub 2015 Sep 29. Review.

PMID:
26419471
18.

Abaloparatide: Recombinant human PTHrP (1-34) anabolic therapy for osteoporosis.

Chew CK, Clarke BL.

Maturitas. 2017 Mar;97:53-60. doi: 10.1016/j.maturitas.2016.12.003. Epub 2016 Dec 15. Review.

PMID:
28159062
19.

New understanding and treatments for osteoporosis.

Mazziotti G, Bilezikian J, Canalis E, Cocchi D, Giustina A.

Endocrine. 2012 Feb;41(1):58-69. doi: 10.1007/s12020-011-9570-2. Review.

PMID:
22180055
20.

Pharmacological topics of bone metabolism: recent advances in pharmacological management of osteoporosis.

Suzuki A, Sekiguchi S, Asano S, Itoh M.

J Pharmacol Sci. 2008 Apr;106(4):530-5. Review.

Supplemental Content

Support Center